Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/31/2002 | CA2416544A1 Mu-conopeptides |
01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
01/31/2002 | CA2416505A1 Method for isolating and characterizing nucleic acid sequences |
01/31/2002 | CA2416496A1 Adhesion molecules |
01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
01/31/2002 | CA2416472A1 Nucleic acids compositions conferring dwarfing phenotype |
01/31/2002 | CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/31/2002 | CA2416414A1 Human kinases |
01/31/2002 | CA2416381A1 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
01/31/2002 | CA2416287A1 Omega-conopeptides |
01/31/2002 | CA2416247A1 Acyl coenzyme a thioesterases |
01/31/2002 | CA2416159A1 Fermentation process for epothilones |
01/31/2002 | CA2415960A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
01/31/2002 | CA2415586A1 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
01/31/2002 | CA2412544A1 Polypeptide delivery ii-2 |
01/31/2002 | CA2412400A1 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof |
01/31/2002 | CA2409415A1 Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures |
01/31/2002 | CA2353106A1 A pcr-based multiplex assay for determining haplotype |
01/30/2002 | EP1176423A1 Surface-attached polyfunctional polymer networks for sensor chips |
01/30/2002 | EP1176413A2 Method of making high density arrays |
01/30/2002 | EP1176215A2 Amplification and detection of mycoplasma pneumoniae |
01/30/2002 | EP1176214A2 Methods for amplifying and detecting Bordetella pertussis |
01/30/2002 | EP1176213A2 Amplification and detection of legionella pneumophila nucleic acids |
01/30/2002 | EP1176211A1 Process for monitoring mutagens in plants |
01/30/2002 | EP1176209A1 Production of Sphingomonas exopolysaccharides unattached to the surface of bacterial cells |
01/30/2002 | EP1176207A2 Production of polyhydroxyalkanoate in plants |
01/30/2002 | EP1176206A2 Barley DEAD box protein HVD1 gene induced by salt stress |
01/30/2002 | EP1176205A2 Expression of alkaline phosphatase in yeast |
01/30/2002 | EP1176204A1 Nuclease |
01/30/2002 | EP1176203A1 Enzyme with improved NAD(H)-acceptance |
01/30/2002 | EP1176202A1 Glucose dehydrogenase |
01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
01/30/2002 | EP1176200A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances |
01/30/2002 | EP1176199A1 Tumor suppressor genes |
01/30/2002 | EP1176198A1 Novel fetal genes |
01/30/2002 | EP1176197A1 A transgenic animal model for cardiac arrhythmias |
01/30/2002 | EP1176196A1 Functional genomic screen for post-transcriptional 5' and 3' regulatory elements |
01/30/2002 | EP1176194A1 Method of cell cultivation |
01/30/2002 | EP1176192A2 Helicobacter felis vaccine |
01/30/2002 | EP1175910A2 Methods and compounds for prevention of graft rejection |
01/30/2002 | EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
01/30/2002 | EP1175510A1 Mismatch repair detection |
01/30/2002 | EP1175508A1 Optical probes and assays |
01/30/2002 | EP1175506A2 Compound screening method |
01/30/2002 | EP1175505A1 Combinatorial chemical library supports having indicia at coding positions and methods of use |
01/30/2002 | EP1175504A1 Dna encoding the human vanilloid receptor vr1 |
01/30/2002 | EP1175503A1 49 human secreted proteins |
01/30/2002 | EP1175501A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
01/30/2002 | EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
01/30/2002 | EP1175496A1 RECOMBINANT i PENICILLIUM FUNICULOSUM /i FOR HOMOLOGOUS AND HETEROLOGOUS PROTEIN PRODUCTION |
01/30/2002 | EP1175495A1 Microbial beta-glucuronidase genes, gene products and uses thereof |
01/30/2002 | EP1175494A1 Beta-hexosaminidase, dna sequence from ciliates for coding the same and use thereof |
01/30/2002 | EP1175493A1 Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants |
01/30/2002 | EP1175492A1 Star homologues |
01/30/2002 | EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics |
01/30/2002 | EP1175490A2 Tyrosine kinase substrate (tks) proteins |
01/30/2002 | EP1175489A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
01/30/2002 | EP1175445A1 Specific antibodies and antibody fragments for tgfbeta1 |
01/30/2002 | EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs |
01/30/2002 | EP1175442A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
01/30/2002 | EP1175440A1 48 human secreted proteins |
01/30/2002 | EP1175439A1 49 human secreted proteins |
01/30/2002 | EP1175438A1 62 human secreted proteins |
01/30/2002 | EP1175436A2 Transiently immortalized cells for use in gene therapy |
01/30/2002 | EP1175431A1 Substrate including anionic detergent for purifying nucleic acid |
01/30/2002 | EP1175430A1 Antisense-oligos with better stability and antisense effect |
01/30/2002 | EP1175228A1 Gene therapy using tgf-beta |
01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
01/30/2002 | EP1175144A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
01/30/2002 | EP1102782A4 Structural analogs of amine bases and nucleosides |
01/30/2002 | EP1071429B1 Map kinase inhibitors in the treatment of disorders caused by tnf-alpha induced lipolysis |
01/30/2002 | EP0956009B1 Treatment of neurodegenerative conditions with nimesulide |
01/30/2002 | EP0929676A4 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
01/30/2002 | EP0904539A4 Inhibiting protein interactions |
01/30/2002 | EP0888373A4 Smooth muscle cell lim protein |
01/30/2002 | EP0879247A4 Glial cell line-derived neurotrophic factor receptors |
01/30/2002 | EP0730495B1 Method and apparatus for collecting a cell sample from a liquid specimen |
01/30/2002 | EP0680605B1 Entrapment of nucleic acid sequencing template in sample mixtures by entangled polymer networks |
01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
01/30/2002 | EP0617736B1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
01/30/2002 | EP0596979B1 Recombinant plant viral nucleic acids |
01/30/2002 | EP0536293B1 Increased starch content in plants |
01/30/2002 | EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin |
01/30/2002 | EP0497922B1 Infective protein delivery system |
01/30/2002 | CN1333873A HIV-specfic T-cell induction |
01/30/2002 | CN1333837A Methods for producing polypeptides in aspergillus mutant cells |
01/30/2002 | CN1333835A Phosphonate metabolizing plants |
01/30/2002 | CN1333834A Vectors for transforming plants |
01/30/2002 | CN1333833A New method of identifying non-host plant disease resistance genes |
01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
01/30/2002 | CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
01/30/2002 | CN1333829A Polypeptide |